Headache News and Research

Latest Headache News and Research

As many American cities get hotter, health systems face off against heatstroke

As the hour crept past three in the afternoon, New Orleans’ French Quarter was devoid of tourists and locals alike. The heat index was over 105 degrees.

7 Aug 2023

NIH awards $18 million to develop novel chikungunya vaccine

The Access to Advanced Health Institute (AAHI) announced today that it has received an $18 million award from the National Institutes of Health (NIH) to develop a temperature stable, single-dose vaccine candidate for the chikungunya virus.

3 Aug 2023

The mechanisms of triptan using metabolomics and transcriptomics in spontaneous migraine attacks

Researchers discuss the mechanisms of triptans for the treatment of spontaneous migraine attacks by using transcriptomics and metabolomics.

3 Aug 2023

Frequent headaches linked to bullying, suicidal tendencies in teens

Teens who have been bullied by their peers, or who have considered or attempted suicide, may be more likely to have more frequent headaches than teens who have not experienced any of these problems, according to a study published in the August 2, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.

2 Aug 2023

Non-invasive brain stimulation shows promise for treating ADHD in children

Non-invasive brain stimulation, combined with cognitive training, could significantly improve symptoms of attention deficit hyperactivity disorder (ADHD) in children, according to new research jointly led by the University of Surrey and the Hebrew University of Jerusalem.

1 Aug 2023

Trial evaluates purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder

Researchers investigated the safety and pharmacokinetics of JNJ-54175446 in a double-blind, multicenter, randomized controlled trial (RCT).

31 Jul 2023

Researchers study the impact of teleneurology program on timeliness of access to neurological care

Accessing neurologic care often presents physical, geographical and financial challenges to patients, many of whom face chronic and disabling conditions.

27 Jul 2023

American Heart Association grants $2.1 million to study migraines and cardiovascular disease

Existing research shows certain types of migraines can increase the risk of stroke, and there is growing evidence that they may also lead to other types of cardiovascular disease (CVD).

26 Jul 2023

New study quantifies the incidence of neuropsychiatric events in children with flu

While the incidence of influenza-associated neuropsychiatric events in children in the United States is unknown, the controversy over the use of a common antiviral medication typically administered to treat flu in children has sparked concern among parents and medical professionals alike.

24 Jul 2023

Comparing COVID-19 symptom burden and quality of life in positive and negative PCR test results

Reports evaluated to what extent symptoms are present before, during, and after a positive SARS-CoV-2 PCR test.

24 Jul 2023

Understanding persistent COVID-19 symptoms: study explores early indicators of long COVID

Researchers investigated early biomarkers of post-acute sequelae of SARS-CoV-2 infection in individuals intensively sampled during the acute phase of COVID-19.

20 Jul 2023

Study explores the effectiveness of caffeine consumption for headaches: trigger or remedy?

Caffeine has a dual role in headaches as it can induces or remediate them.

20 Jul 2023

Study finds gender bias in stroke treatment

Despite having worse stroke symptoms and living within comparable distances to comprehensive stroke centers, women with large vessel occlusion acute ischemic stroke are less likely to be routed to the centers compared to men, according to a new study from UTHealth Houston.

18 Jul 2023

Novel vaccine against Lyme disease reported to be safe and effective

Researchers determine the safety and immunogenicity of a novel candidate vaccine against Lyme borreliosis.

11 Jul 2023

Lilly granted MHRA marketing authorization in Great Britain for a ground-breaking UC therapy

Eli Lilly and Company announced today that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation (MA) for mirikizumab (OMVOH®) for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic treatment.

10 Jul 2023

Moderna provides an update on regulatory submissions for RSV vaccine candidate, mRNA-1345

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today provided an update on regulatory submissions for mRNA-1345, a vaccine for the prevention of RSV-associated lower respiratory tract disease (RSV-LRTD) and acute respiratory disease (ARD) in adults aged 60 years or older.

10 Jul 2023

New regulatory system discovered in malaria parasite

Gene expression within the apicoplast, an organelle in the malaria parasite Plasmodium falciparum, is regulated by melatonin (the circadian signaling hormone) in host blood, and intrinsic parasite cues, via a factor called ApSigma, as identified by a recent study aided by Tokyo Tech's World Research Hub Initiative.

3 Jul 2023

Headache News and Research

Latest Headache News and Research

As many American cities get hotter, health systems face off against heatstroke

NIH awards $18 million to develop novel chikungunya vaccine

The mechanisms of triptan using metabolomics and transcriptomics in spontaneous migraine attacks

Frequent headaches linked to bullying, suicidal tendencies in teens

Non-invasive brain stimulation shows promise for treating ADHD in children

Trial evaluates purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder

Researchers study the impact of teleneurology program on timeliness of access to neurological care

American Heart Association grants $2.1 million to study migraines and cardiovascular disease

New study quantifies the incidence of neuropsychiatric events in children with flu

Comparing COVID-19 symptom burden and quality of life in positive and negative PCR test results

Understanding persistent COVID-19 symptoms: study explores early indicators of long COVID

Study explores the effectiveness of caffeine consumption for headaches: trigger or remedy?

Study finds gender bias in stroke treatment

Novel vaccine against Lyme disease reported to be safe and effective

Lilly granted MHRA marketing authorization in Great Britain for a ground-breaking UC therapy

Moderna provides an update on regulatory submissions for RSV vaccine candidate, mRNA-1345

New regulatory system discovered in malaria parasite

AEM systematic review provides new insights into head imaging abnormalities in patients with acute delirium

Long COVID cannot be treated as a single condition, study says

WHO to declare artificial sweetener aspartame as possible carcinogen

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Headache News and Research

Latest Headache News and Research

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in